{"id":41634,"date":"2025-04-26T18:23:25","date_gmt":"2025-04-26T12:53:25","guid":{"rendered":"https:\/\/financialtelegraph.in\/index.php\/2025\/04\/26\/thyrocare-q4fy25-revenue-up-21-percent-yoy-to-rs-187-2-cr-pat-rises-24-percent-to-rs-21-3-cr\/"},"modified":"2025-04-26T18:23:25","modified_gmt":"2025-04-26T12:53:25","slug":"thyrocare-q4fy25-revenue-up-21-percent-yoy-to-rs-187-2-cr-pat-rises-24-percent-to-rs-21-3-cr","status":"publish","type":"post","link":"https:\/\/financialtelegraph.in\/index.php\/2025\/04\/26\/thyrocare-q4fy25-revenue-up-21-percent-yoy-to-rs-187-2-cr-pat-rises-24-percent-to-rs-21-3-cr\/","title":{"rendered":"Thyrocare Q4FY25 Revenue Up 21 Percent YoY to Rs 187.2 Cr; PAT Rises 24 Percent to Rs 21.3 Cr"},"content":{"rendered":"<div>\n<p><img loading=\"lazy\" width=\"1200\" height=\"675\" src=\"https:\/\/financialtelegraph.in\/wp-content\/uploads\/2025\/04\/PNN1200x675-2604-15.jpg\" class=\"attachment-post-thumbnail size-post-thumbnail wp-post-image\" alt=\"Thyrocare\" decoding=\"async\" srcset=\"https:\/\/financialtelegraph.in\/wp-content\/uploads\/2025\/04\/PNN1200x675-2604-15.jpg 1200w, https:\/\/pnndigital.com\/wp-content\/uploads\/2025\/04\/PNN1200x675-2604-15-300x169.jpg 300w, https:\/\/pnndigital.com\/wp-content\/uploads\/2025\/04\/PNN1200x675-2604-15-1024x576.jpg 1024w, https:\/\/pnndigital.com\/wp-content\/uploads\/2025\/04\/PNN1200x675-2604-15-768x432.jpg 768w, https:\/\/pnndigital.com\/wp-content\/uploads\/2025\/04\/PNN1200x675-2604-15-150x84.jpg 150w, https:\/\/pnndigital.com\/wp-content\/uploads\/2025\/04\/PNN1200x675-2604-15-450x253.jpg 450w\" sizes=\"auto, (max-width: 1200px) 100vw, 1200px\"><\/p>\n<p><span data-sheets-root=\"1\"><strong>Navi Mumbai (Maharashtra) [India], April 24:<\/strong> <\/span>Thyrocare Technologies Limited (hereinafter referred to as \u201c<strong>Thyrocare<\/strong>\u201d NSE: THYROCARE, BSE: 539871), a leading healthcare diagnostics company, announces their results for the quarter ended March 31, 2025. For Q4FY25, the company reported revenue from operations of INR 187.2 crore, reflecting a 21% year-over-year (YoY) growth. Normalized EBITDA for the quarter stood at INR 65.3 crore, marking a robust 78% YoY increase. Profit after tax (PAT), excluding exceptional items, reached INR 32.5 crore, which represents an impressive 88% YoY growth.<b>Thyrocare Technologies Limited<\/b><\/p>\n<p><strong>Key highlights for Q4FY25:<\/strong><\/p>\n<ul>\n<li>Consolidated revenue increased by 21% year-over-year (YoY) with Pathology and Radiology segments growing by 23% YoY and 7% YoY respectively<\/li>\n<li>Total volume in FY25 grew to 167.9 million, largest by far on volume<\/li>\n<li>Revenue from franchise surged by 22% YoY, and partnership revenue saw 24% YoY growth<\/li>\n<li>Consolidated gross margin stood at 74%, and normalized EBITDA margin was 35%<\/li>\n<li>Standalone normalized EBITDA grew by 72% YoY, while PAT* increased by 72% YoY<\/li>\n<li>Consolidated normalized EBITDA grew by 78% YoY, while PAT* increased by 88% YoY<\/li>\n<li>Recommended a final dividend of INR 21 per equity share subject to the approval of shareholders at the ensuing shareholders meeting<\/li>\n<li>Consolidated cash reserves as of March 2025 is INR 191.8 Cr<\/li>\n<li>Opened new labs in Bhagalpur and Kashmir<\/li>\n<\/ul>\n<p><strong>Consolidated income statement for Q4FY25 and FY25<\/strong><strong>:<\/strong><\/p>\n<table border=\"1\" width=\"629\" cellspacing=\"0\" cellpadding=\"0\">\n<tbody>\n<tr>\n<td valign=\"top\" width=\"36.56597774244833%\"><\/td>\n<td colspan=\"3\" valign=\"top\" width=\"30.842607313195547%\"><strong>Quarter<\/strong><\/td>\n<td colspan=\"3\" valign=\"top\" width=\"32.591414944356124%\"><strong>Annual<\/strong><\/td>\n<\/tr>\n<tr>\n<td valign=\"top\" width=\"36.56597774244833%\"><strong>INR Crore<\/strong><\/td>\n<td valign=\"top\" width=\"11.605723370429253%\"><strong>Q4FY25<\/strong><\/td>\n<td valign=\"top\" width=\"11.605723370429253%\"><strong>Q4FY24<\/strong><\/td>\n<td valign=\"top\" width=\"7.631160572337043%\"><strong>YoY<\/strong><\/td>\n<td valign=\"top\" width=\"12.400635930047695%\"><strong>FY25<\/strong><\/td>\n<td valign=\"top\" width=\"12.559618441971383%\"><strong>FY24<\/strong><\/td>\n<td valign=\"top\" width=\"7.631160572337043%\"><strong>YoY<\/strong><\/td>\n<\/tr>\n<tr>\n<td valign=\"top\" width=\"36.56597774244833%\">Revenue from operations<\/td>\n<td valign=\"top\" width=\"11.605723370429253%\">187.2<\/td>\n<td valign=\"top\" width=\"11.605723370429253%\">154.2<\/td>\n<td valign=\"top\" width=\"7.631160572337043%\">21%<\/td>\n<td valign=\"top\" width=\"12.400635930047695%\">687.3<\/td>\n<td valign=\"top\" width=\"12.559618441971383%\">571.9<\/td>\n<td valign=\"top\" width=\"7.631160572337043%\">20%<\/td>\n<\/tr>\n<tr>\n<td valign=\"top\" width=\"36.56597774244833%\">Gross margin<\/td>\n<td valign=\"top\" width=\"11.605723370429253%\">137.7<\/td>\n<td valign=\"top\" width=\"11.605723370429253%\">107.6<\/td>\n<td valign=\"top\" width=\"7.631160572337043%\">28%<\/td>\n<td valign=\"top\" width=\"12.400635930047695%\">496.2<\/td>\n<td valign=\"top\" width=\"12.559618441971383%\">405.2<\/td>\n<td valign=\"top\" width=\"7.631160572337043%\">22%<\/td>\n<\/tr>\n<tr>\n<td valign=\"top\" width=\"36.56597774244833%\">Normalized EBITDA (before ESOP)<\/td>\n<td valign=\"top\" width=\"11.605723370429253%\">65.3<\/td>\n<td valign=\"top\" width=\"11.605723370429253%\">36.7<\/td>\n<td valign=\"top\" width=\"7.631160572337043%\">78%<\/td>\n<td valign=\"top\" width=\"12.400635930047695%\">209.9<\/td>\n<td valign=\"top\" width=\"12.559618441971383%\">153.1<\/td>\n<td valign=\"top\" width=\"7.631160572337043%\">37%<\/td>\n<\/tr>\n<tr>\n<td valign=\"top\" width=\"36.56597774244833%\">Reported EBITDA<\/td>\n<td valign=\"top\" width=\"11.605723370429253%\">57.4<\/td>\n<td valign=\"top\" width=\"11.605723370429253%\">33.8<\/td>\n<td valign=\"top\" width=\"7.631160572337043%\">70%<\/td>\n<td valign=\"top\" width=\"12.400635930047695%\">189.2<\/td>\n<td valign=\"top\" width=\"12.559618441971383%\">137.8<\/td>\n<td valign=\"top\" width=\"7.631160572337043%\">37%<\/td>\n<\/tr>\n<tr>\n<td valign=\"top\" width=\"36.56597774244833%\">Profit after tax incl. exceptional item<\/td>\n<td valign=\"top\" width=\"11.605723370429253%\">21.3<\/td>\n<td valign=\"top\" width=\"11.605723370429253%\">17.2<\/td>\n<td valign=\"top\" width=\"7.631160572337043%\">24%<\/td>\n<td valign=\"top\" width=\"12.400635930047695%\">90.0<\/td>\n<td valign=\"top\" width=\"12.559618441971383%\">69.8<\/td>\n<td valign=\"top\" width=\"7.631160572337043%\">29%<\/td>\n<\/tr>\n<tr>\n<td valign=\"top\" width=\"36.56597774244833%\">Profit after tax excl. exceptional item<\/td>\n<td valign=\"top\" width=\"11.605723370429253%\">32.5<\/td>\n<td valign=\"top\" width=\"11.605723370429253%\">17.2<\/td>\n<td valign=\"top\" width=\"7.631160572337043%\">88%<\/td>\n<td valign=\"top\" width=\"12.400635930047695%\">101.2<\/td>\n<td valign=\"top\" width=\"12.559618441971383%\">69.8<\/td>\n<td valign=\"top\" width=\"7.631160572337043%\">45%<\/td>\n<\/tr>\n<tr>\n<td valign=\"top\" width=\"36.56597774244833%\"><strong><u>Key metrics<\/u><\/strong><\/td>\n<td valign=\"top\" width=\"11.605723370429253%\"><\/td>\n<td valign=\"top\" width=\"11.605723370429253%\"><\/td>\n<td valign=\"top\" width=\"7.631160572337043%\"><\/td>\n<td valign=\"top\" width=\"12.400635930047695%\"><\/td>\n<td valign=\"top\" width=\"12.559618441971383%\"><\/td>\n<td valign=\"top\" width=\"7.631160572337043%\"><\/td>\n<\/tr>\n<tr>\n<td valign=\"top\" width=\"36.56597774244833%\">Gross margin%<\/td>\n<td valign=\"top\" width=\"11.605723370429253%\">74%<\/td>\n<td valign=\"top\" width=\"11.605723370429253%\">70%<\/td>\n<td valign=\"top\" width=\"7.631160572337043%\"><\/td>\n<td valign=\"top\" width=\"12.400635930047695%\">72%<\/td>\n<td valign=\"top\" width=\"12.559618441971383%\">71%<\/td>\n<td valign=\"top\" width=\"7.631160572337043%\"><\/td>\n<\/tr>\n<tr>\n<td valign=\"top\" width=\"36.56597774244833%\">Normalized EBITDA%<\/td>\n<td valign=\"top\" width=\"11.605723370429253%\">35%<\/td>\n<td valign=\"top\" width=\"11.605723370429253%\">24%<\/td>\n<td valign=\"top\" width=\"7.631160572337043%\"><\/td>\n<td valign=\"top\" width=\"12.400635930047695%\">31%<\/td>\n<td valign=\"top\" width=\"12.559618441971383%\">27%<\/td>\n<td valign=\"top\" width=\"7.631160572337043%\"><\/td>\n<\/tr>\n<tr>\n<td valign=\"top\" width=\"36.56597774244833%\">Reported EBITDA%<\/td>\n<td valign=\"top\" width=\"11.605723370429253%\">31%<\/td>\n<td valign=\"top\" width=\"11.605723370429253%\">22%<\/td>\n<td valign=\"top\" width=\"7.631160572337043%\"><\/td>\n<td valign=\"top\" width=\"12.400635930047695%\">28%<\/td>\n<td valign=\"top\" width=\"12.559618441971383%\">24%<\/td>\n<td valign=\"top\" width=\"7.631160572337043%\"><\/td>\n<\/tr>\n<tr>\n<td valign=\"top\" width=\"36.56597774244833%\">PAT incl. exceptional item%<\/td>\n<td valign=\"top\" width=\"11.605723370429253%\">11%<\/td>\n<td valign=\"top\" width=\"11.605723370429253%\">11%<\/td>\n<td valign=\"top\" width=\"7.631160572337043%\"><\/td>\n<td valign=\"top\" width=\"12.400635930047695%\">13%<\/td>\n<td valign=\"top\" width=\"12.559618441971383%\">12%<\/td>\n<td valign=\"top\" width=\"7.631160572337043%\"><\/td>\n<\/tr>\n<tr>\n<td valign=\"top\" width=\"36.56597774244833%\">PAT excl. exceptional item%<\/td>\n<td valign=\"top\" width=\"11.605723370429253%\">17%<\/td>\n<td valign=\"top\" width=\"11.605723370429253%\">11%<\/td>\n<td valign=\"top\" width=\"7.631160572337043%\"><\/td>\n<td valign=\"top\" width=\"12.400635930047695%\">14%<\/td>\n<td valign=\"top\" width=\"12.559618441971383%\">12%<\/td>\n<td valign=\"top\" width=\"7.631160572337043%\"><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong><u><br \/>\n<\/u><\/strong>* PAT excluding exceptional item of INR 11.2 Cr pertaining to reversal of deferred tax asset created in previous years against the impairment of investment in NHL.<\/p>\n<p><em>If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.<\/em><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Navi Mumbai (Maharashtra) [India], April 24: Thyrocare Technologies Limited (hereinafter referred to as \u201cThyrocare\u201d NSE: THYROCARE, BSE: 539871), a leading healthcare diagnostics company, announces their results for the quarter ended &hellip; <a href=\"https:\/\/financialtelegraph.in\/index.php\/2025\/04\/26\/thyrocare-q4fy25-revenue-up-21-percent-yoy-to-rs-187-2-cr-pat-rises-24-percent-to-rs-21-3-cr\/\" class=\"more-link\">Read More<\/a><\/p>\n","protected":false},"author":1,"featured_media":41635,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[673],"tags":[674],"class_list":["post-41634","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-finance","tag-finance","entry"],"_links":{"self":[{"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/posts\/41634","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/comments?post=41634"}],"version-history":[{"count":0,"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/posts\/41634\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/media\/41635"}],"wp:attachment":[{"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/media?parent=41634"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/categories?post=41634"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/tags?post=41634"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}